Abatacept for treatment of severe treatment-resistant morphoea (localised scleroderma)

Abatacept is recommended as a treatment option through routine commissioning for adults and children 2 years and over with severe, treatment resistant morphoea within the criteria set out in the commissioning policy.

NHS England